Stay updated on Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Sign up to get notified when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.

Latest updates to the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page
- Check6 days agoChange DetectedAdds Melanoma topic tag and MedlinePlus Genetics related topics, and updates the page revision to v3.4.3 (removing v3.4.2).SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedMelanoma and the related topic MedlinePlus Genetics were removed from the page. This reduces disease context and navigation to related resources for this melanoma study.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now includes melanoma-related terms and MedlinePlus Genetics as a related topic, and the version shows Revision: v3.4.2. It removes a government funding lapse notice and the prior Revision: v3.4.1.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide funding notice with status updates and a new Revision: v3.4.1 were added, while the related topics 'Melanoma' and 'MedlinePlus Genetics' and the older 'Revision: v3.4.0' were removed. This does not alter the study content or participation details.SummaryDifference0.7%

- Check48 days agoChange DetectedAdded glossary and related topic links (e.g., Melanoma, MedlinePlus Genetics) to improve reader understanding. Updated metadata notes reflect Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while older terms (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4) were removed.SummaryDifference0.4%

- Check56 days agoChange DetectedThe Melanoma topic and related MedlinePlus Genetics links were removed from the study page.SummaryDifference0.2%

Stay in the know with updates to Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Leflunomide+Vemurafenib in V600 Met. Melanoma Clinical Trial page.